Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 10, 2009 - Issue 2
Submit an article Journal homepage
2,806
Views
55
CrossRef citations to date
0
Altmetric
Original Investigations

Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

Gerald Stöber Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, GermanyCorrespondence[email protected]
,
Dorit Ben-Shachar Research Laboratorium of Psychobiology, Department of Psychiatry–Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Bat Galim, Haifa, Israel
,
M. Cardon The Weizmann Institute of Science, Department of Neurobiology, Rehovot, 76100, Israel
,
Peter Falkai Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany
,
Alfred N. Fonteh Molecular Neurology Program, Huntington Medical Research Institutes, Pasadena, CA, USA
,
Micha Gawlik Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany
,
Birte Y. Glenthoj Center for Neuropsychiatric Schizophrenia Research, Faculty of Health Sciences, University Psychiatric Center Glostrup, Copenhagen University, Glostrup, Denmark
,
Edna Grünblatt Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany
,
Assen Jablensky Centre for Clinical Research in Neuropsychiatry, The University of Western Australia, Perth, Western Australia, Australia
,
Yong-Ku Kim Department of Psychiatry, Korea University College of Medicine, Ansan Hospital, Ansan City, Korea
,
Johannes Kornhuber Department of Psychiatry and Psychotherapy, University of Erlangen, Erlangen, Germany
,
Thomas F. McNeil Unit of Psychiatric Epidemiology, University Hospital, Lund, Sweden
,
Norbert Müller Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, München, Germany
,
Bob Oranje Center for Neuropsychiatric Schizophrenia Research, Faculty of Health Sciences, University Psychiatric Center Glostrup, Copenhagen University, Glostrup, Denmark
,
Toshikazu Saito Department of Neurology, Kitasato University School of Medicine, Kanagawa, Japan
,
Mohamed Saoud SHU de Psychiatrie, Centre Hospitalier Le Vinatier, Bron-Lyon, France
,
Andrea Schmitt Department of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany
,
Michal Schwartz The Weizmann Institute of Science, Department of Neurobiology, Rehovot, 76100, Israel
,
Johannes Thome Academic Unit of Psychiatry, Institute of Life Science, The School of Medicine, University of Wales Swansea, Swansea, UK
,
Marat Uzbekov Department of Brain Pathology, Research Institute of Psychiatry, Moscow, Russia
,
Nuria Durany Department of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain
&
Peter Riederer Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, GermanyCorrespondence[email protected]
 show all
Pages 127-155 | Published online: 12 Jul 2009

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Jun-Hua Gao, Wu-Rong Li, Dong-Mei Xu, Bo-Wen Zheng, Yu-Ming Huang, Wen-Qing Wu & Wei Zhang. (2021) Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane. Neuropsychiatric Disease and Treatment 17, pages 69-78.
Read now
Andrea Schmitt, Dan Rujescu, Micha Gawlik, Alkomiet Hasan, Kenji Hashimoto, Sylvain Iceta, Marek Jarema, Joseph Kambeitz, Siegfried Kasper, Daniel Keeser, Johannes Kornhuber, Nikolaos Koutsouleris, Rupert Lanzenberger, Berend Malchow, Mohamed Saoud, Marie Spies, Gerald Stöber, Florence Thibaut, Peter Riederer & Peter Falkai. (2016) Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics. The World Journal of Biological Psychiatry 17:6, pages 406-428.
Read now
Borwin Bandelow, David Baldwin, Marianna Abelli, Carlo Altamura, Bernardo Dell’Osso, Katharina Domschke, Naomi A. Fineberg, Edna Grünblatt, Marek Jarema, Eduard Maron, David Nutt, Stefano Pini, Matilde M. Vaghi, Adam Wichniak, Gwyneth Zai & Peter Riederer. (2016) Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics. The World Journal of Biological Psychiatry 17:5, pages 321-365.
Read now
Daphne Voineskos & Zafiris J Daskalakis. (2013) A primer on the treatment of schizophrenia through repetitive transcranial magnetic stimulation. Expert Review of Neurotherapeutics 13:10, pages 1079-1082.
Read now
Emanuel Schwarz, Paul C. Guest, Hassan Rahmoune, Daniel Martins-de-Souza, David W. Niebuhr, Natalya S. Weber, David N. Cowan, Robert H. Yolken, Michael Spain, Anthony Barnes & Sabine Bahn. (2012) Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation. The World Journal of Biological Psychiatry 13:8, pages 627-632.
Read now
Tanja Maria Michel, Abigail Jane Sheldrick, Sybille Camara, Edna Grünblatt, Frank Schneider & Peter Riederer. (2011) Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia. The World Journal of Biological Psychiatry 12:8, pages 588-597.
Read now
Ivan Koychev, Wael El-Deredy & John Francis William Deakin. (2011) New visual information processing abnormality biomarkers for the diagnosis of schizophrenia. Expert Opinion on Medical Diagnostics 5:4, pages 357-368.
Read now
Eva Ceskova, Radovan Prikryl & Tomas Kasparek. (2011) Outcome in males with first-episode schizophrenia: 7-year follow-up. The World Journal of Biological Psychiatry 12:1, pages 66-72.
Read now
Hubertus Himmerich, Kenneth Clifford Kirkby & Holger Steinberg. (2010) From Julius Wagner-Jauregg to biomarkers and immunological therapies. The World Journal of Biological Psychiatry 11:2, pages 154-155.
Read now

Articles from other publishers (46)

Marat G. Uzbekov. (2023) Pathogenetic Mechanisms of Mental Disorders: Endogenous Intoxication. Biochemistry (Moscow) 88:4, pages 491-501.
Crossref
Jack R. Foucher, Andreas J. Bartsch, Olivier Mainberger, Laurent Vercueil, Clément C. de Billy, Alexandre Obrecht, Hippolyte Arcay, Fabrice Berna, Julie M.E. Clauss, Sébastien Weibel, Markus Hanke, Julien Elowe, Benoit Schorr, Efflam Bregeon, Birgit Braun, Marcelo Cetkovich, Burkhard E. Jabs, Thomas Dorfmeister, Gabor S. Ungvari, Ludovic C. Dormegny-Jeanjean & Bruno Pfuhlmann. (2022) Parakinesia: A Delphi consensus report. Schizophrenia Research.
Crossref
М.Г. Узбеков. (2021) Моноаминоксидаза как потенциальный биологический маркер эффективности терапии психических заболеваний. Биохимия 86:6, pages 933-944.
Crossref
Marat G. Uzbekov. (2021) Monoamine Oxidase as a Potential Biomarker of the Efficacy of Treatment of Mental Disorders. Biochemistry (Moscow) 86:6, pages 773-783.
Crossref
Dirk Roosterman & Graeme Stuart Cottrell. (2021) The two-cell model of glucose metabolism: a hypothesis of schizophrenia. Molecular Psychiatry 26:6, pages 1738-1747.
Crossref
Mei-Chi Hsu, Yung-Sheng Huang & Wen-Chen Ouyang. (2020) Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms. Lipids in Health and Disease 19:1.
Crossref
Aleksandra Aleksandrowicz, Florence Hagenmuller, Helene Haker, Karsten Heekeren, Anastasia Theodoridou, Susanne Walitza, Ann-Christine Ehlis, Andreas Fallgatter, Wulf Rössler & Wolfram Kawohl. (2020) Frontal brain activity in individuals at risk for schizophrenic psychosis and bipolar disorder during the emotional Stroop task – an fNIRS study. NeuroImage: Clinical 26, pages 102232.
Crossref
Damodharan Dinakaran, Vanteemar S. Sreeraj & Ganesan Venkatasubramanian. 2020. Schizophrenia Treatment Outcomes. Schizophrenia Treatment Outcomes 85 89 .
T. I. Syrejshchikova, N. V. Smolina, V. V. Brilliantova, E. D. Syromyatnikova, M. G. Uzbekov & G. E. Dobretsov. (2019) Time-Resolved Tryptophan Fluorescence as an Indicator of Alterations in Serum Proteins in Melancholic Depression. Biophysics 64:1, pages 95-99.
Crossref
Leticia González-Blanco, María Paz García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2018) Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. Revista de Psiquiatría y Salud Mental (English Edition) 11:3, pages 130-140.
Crossref
Leticia González-Blanco, María Paz García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2018) Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia. Revista de Psiquiatría y Salud Mental 11:3, pages 130-140.
Crossref
N Bak, B H Ebdrup, B Oranje, B Fagerlund, M H Jensen, S W Düring, M Ø Nielsen, B Y Glenthøj & L K Hansen. (2017) Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology. Translational Psychiatry 7:4, pages e1087-e1087.
Crossref
Matea Perkovic, Gordana Erjavec, Dubravka Strac, Suzana Uzun, Oliver Kozumplik & Nela Pivac. (2017) Theranostic Biomarkers for Schizophrenia. International Journal of Molecular Sciences 18:4, pages 733.
Crossref
T. I. Syrejshchikova, N. V. Smolina, V. V. Brilliantova, M. G. Uzbekov & G. E. Dobretsov. (2017) Albumin binding-site alteration in melancholic depression under pharmacotherapy: Recording with the use of subnanosecond fluorescence spectroscopy. Biophysics 62:2, pages 286-290.
Crossref
Micha Gawlik, Martin Wagner, Bruno Pfuhlmann & Gerald Stöber. (2015) The role of Pannexin gene variants in schizophrenia: systematic analysis of phenotypes. European Archives of Psychiatry and Clinical Neuroscience 266:5, pages 433-437.
Crossref
Ladislav Hosák. (2016) Biomarkers of schizophrenia - a brief review and the recent knowledge. Psychiatrie pro praxi 17:2, pages 44-47.
Crossref
Stephanie Fryar-Williams & Jörg E. Strobel. (2016) Biomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance. Frontiers in Psychiatry 7.
Crossref
Nora Bedrossian, Mariam Haidar, Jawad Fares, Firas H. Kobeissy & Youssef Fares. (2016) Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia. Frontiers in Molecular Neuroscience 9.
Crossref
Holger Steinberg, Kenneth Kirkby & Hubertus Himmerich. (2015) The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy. International Journal of Molecular Sciences 16:12, pages 28841-28869.
Crossref
Stephanie Fryar-Williams & Jörg E Strobel. (2015) Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomarker Research 3:1.
Crossref
Khaled Al Awam, Ida Sibylle Haußleiter, Ed Dudley, Rossen Donev, Martin Brüne, Georg Juckel & Johannes Thome. (2014) Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. Journal of Neural Transmission 122:S1, pages 111-122.
Crossref
Stephanie Fryar-Williams & Jörg E. Strobel. (2015) Biomarker Symptom Profiles for Schizophrenia and Schizoaffective Psychosis. Open Journal of Psychiatry 05:01, pages 78-112.
Crossref
T. I. Syrejshchikova, N. V. Smolina, M. G. Uzbekov, G. E. Dobretsov, V. V. Kalinina, V. V. Krujkov, O. S. Antipova, I. N. Emel’yanova & V. N. Krasnov. (2015) Disturbance of serum albumin conformation in patients with melancholic depression. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:1. Vyp. 2, pages 56.
Crossref
Naoki Hashimoto, Atsuhito Toyomaki, Minoru Honda, Satoru Miyano, Nobuyuki Nitta, Hiroyuki Sawayama, Yasufumi Sugawara, Keiichi Uemura, Noriko Tsukamoto, Tsukasa Koyama & Ichiro Kusumi. (2015) Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study. Annals of General Psychiatry 14:1, pages 1.
Crossref
Szatmár Horváth & Károly Mirnics. (2015) Schizophrenia as a Disorder of Molecular Pathways. Biological Psychiatry 77:1, pages 22-28.
Crossref
M. G. Uzbekov & N. M. Maximova. (2014) The relationship between the monoaminergic and hormonal systems and endogenous intoxication in mixed anxiety-depressive disorder. Neurochemical Journal 8:4, pages 311-318.
Crossref
F. Friedrich, M. Aigner, N. Fearns, M.E. Friedrich, R. Frey & A. Geusau. (2014) Psychosis in Neurosyphilis - Clinical Aspects and Implications. Psychopathology 47:1, pages 3-9.
Crossref
S. A. Ivanova, L. P. Smirnova, Yu. G. Shchigoreva, A. S. Boiko, A. V. Semke, M. G. Uzbekov & N. A. Bokhan. (2014) Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics. Neurochemical Journal 8:1, pages 66-70.
Crossref
A. Carlo Altamura, Massimiliano Buoli & Sara Pozzoli. (2014) Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia. Psychiatry and Clinical Neurosciences 68:1, pages 21-36.
Crossref
Kyoung-Sae Na, Han-Yong Jung & Yong-Ku Kim. (2014) The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, pages 277-286.
Crossref
Marat G. Uzbekov, Eduard Misionzhnik, Isaak Gurovich, Alexander Shmukler & Tatjana Moskvitina. (2013) Aspects of metabolic changes in first-episode drug-naïve schizophrenic patients. Acta Neuropsychiatrica 25:5, pages 268-274.
Crossref
Sabrina Schneider, Thomas Juergen Bahmer, Florian Gerhard Metzger, Andreas Reif, Thomas Polak, Bruno Pfuhlmann, Gudrun Walter, Mark-Christian Eberle, Lena Helene Ernst, Andreas Jochen Fallgatter & Ann-Christine Ehlis. (2013) Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study. International Journal of Neuropsychopharmacology 16:9, pages 1911-1925.
Crossref
Radovan Prikryl, Eva Ceskova, Silva Tronerova, Tomas Kasparek, Hana Prikrylova Kucerova, Libor Ustohal, Simona Venclikova & Michaela Vrzalova. (2012) Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia. Psychiatry Research 200:2-3, pages 67-72.
Crossref
I. Koychev, W. El‐Deredy, T. Mukherjee, C. Haenschel & J. F. W. Deakin. (2012) Core dysfunction in schizophrenia: electrophysiology trait biomarkers. Acta Psychiatrica Scandinavica 126:1, pages 59-71.
Crossref
Melissa Raven, Geoffrey W Stuart & Jon Jureidini. (2012) ‘Prodromal’ diagnosis of psychosis: Ethical problems in research and clinical practice. Australian & New Zealand Journal of Psychiatry 46:1, pages 64-65.
Crossref
H. Himmerich, S. Sorge, K.C. Kirkby & H. Steinberg. (2011) Schizophrene StörungenSchizophrenic disorders. Der Nervenarzt 83:1, pages 7-15.
Crossref
Hubertus Himmerich. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 435 440 .
Jiekun Xuan, Guihua Pan, Yunping Qiu, Lun Yang, Mingming Su, Yumin Liu, Jian Chen, Guoyin Feng, Yiru Fang, Wei Jia, Qinghe Xing & Lin He. (2011) Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action. Journal of Proteome Research 10:12, pages 5433-5443.
Crossref
Alejandro Gella, Mònica Segura, Núria Durany, Bruno Pfuhlmann, Gerald Stöber & Micha Gawlik. (2011) Is Ankyrin a genetic risk factor for psychiatric phenotypes?. BMC Psychiatry 11:1.
Crossref
Robert D. Oades. (2011) An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD). ADHD Attention Deficit and Hyperactivity Disorders 3:4, pages 301-318.
Crossref
M. P. Vawter, F. Mamdani & F. Macciardi. (2011) An integrative functional genomics approach for discovering biomarkers in schizophrenia. Briefings in Functional Genomics 10:6, pages 387-399.
Crossref
A. Raballo & J. Parnas. (2010) The Silent Side of the Spectrum: Schizotypy and the Schizotaxic Self. Schizophrenia Bulletin 37:5, pages 1017-1026.
Crossref
Julie Bor, Jérôme Brunelin, Thierry d'Amato, Nicolas Costes, Marie-Françoise Suaud-Chagny, Mohamed Saoud & Emmanuel Poulet. (2011) How can cognitive remediation therapy modulate brain activations in schizophrenia?. Psychiatry Research: Neuroimaging 192:3, pages 160-166.
Crossref
STEPHEN M. LAWRIE, BAYANNE OLABI, JEREMY HALL & ANDREW M. McINTOSH. (2011) Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?. World Psychiatry 10:1, pages 19-31.
Crossref
Sheena Lindsey Waters-Metenier & Timothea Toulopoulou. (2010) Qualifying brain functional MRI parameters as endophenotypes in schizophrenia. Future Neurology 5:6, pages 817-838.
Crossref
Alex J Mitchell & Timothy G Dinan. (2010) Schizophrenia: a multisystem disease?. Journal of Psychopharmacology 24:4_suppl, pages 5-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.